Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Biochimico Pavese PhafiledCriticalIstituto Biochimico Pavese Pha
Priority to ITMI980092priorityCriticalpatent/IT1298164B1/it
Publication of ITMI980092A1publicationCriticalpatent/ITMI980092A1/it
Application grantedgrantedCritical
Publication of IT1298164B1publicationCriticalpatent/IT1298164B1/it
ITMI9800921998-01-201998-01-20Impiego di allantoina come unico principio attivo antivirale per il trattamento e la profilassi dell'herpes simplex
IT1298164B1
(it)
Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano